Two Fox Chase Cancer Center urologic oncologists participated in presentations at the spring 2018 annual meeting of the American Urological Association (AUA) and the Society for Urologic Oncology (SUO).Rosalia Viterbo, MD, FACS, brought her extensive experi...
Read More about Spring 2018 AUA & SUO Presentations
While the standard of care for muscle invasive bladder cancer is to remove the entire bladder, in some 30 percent of patients, these organs do not harbor residual cancer, especially after chemotherapy treatment. Today, there is no reliable way to identif...
Read More about How to Find the 30 Percent: Tackling Diagnostic Challenges Following Muscle Invasive Bladder Cancer Treatment
When it comes to keeping cancer at bay, there’s both good news and bad.The bad news is that there’s no foolproof way to prevent it. As for the good? Everyone can take steps to significantly lower their risk. “Cancer can be genetic or sporadic,” said Sanjay ...
Read More about 8 Ways to Reduce Your Risk for Cancer
By harnessing the patient’s own immune system to counterattack lung cancer cells, immunotherapy medications are a revolutionary new approach to treating this disease. Lung cancer is the second most common cancer in the U.S. and by far the leading cause of d...
Read More about The Battle Against Lung Cancer Has a New Weapon: Immunotherapy.
Updated 2/16/2021 Updates were reviewed by Shazia K. Nakhoda, MD While lymphoma is the most common type of blood cancer, there are many different subtypes that require nuanced treatment. Because of this, getting an accurate diagnosis and receiving ind...
Read More about Everything You Need to Know About Lymphoma
Updated: February 13, 2020After a cancer diagnosis, lots of decisions need to be made. One that many patients face is whether or not to have a catheter or a port—or both—inserted. These can be used for blood draws and intravenous (IV) chemotherapy treatment...
Read More about Catheters and Ports for Cancer Treatment: Your Questions Answered
